Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
about
Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteersSystematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infectionsAsymmetric dimethyarginine as marker and mediator in ischemic strokeAsymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studiesEffects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry.Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trialIncidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomerania.Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipientsEndothelial dysfunction and brachial intima-media thickness: long term cardiovascular risk with claudication related to peripheral arterial disease: a prospective analysis.L-Arginine and SDMA Serum Concentrations Are Associated with Subclinical Atherosclerosis in the Study of Health in Pomerania (SHIP)Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective StudiesThe relationship of nitric oxide synthesis capacity, oxidative stress, and albumin-to-creatinine ratio in black and white men: the SABPA studyDifferential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.Investigating the role of acute mental stress on endothelial dysfunction: a systematic review and meta-analysis.A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations.A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis.Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort.Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients.Nitric oxide synthesis capacity, ambulatory blood pressure and end organ damage in a black and white population: the SABPA study.Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study.Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.Hypertension subtypes modify metabolic response to thiazide diuretics.Endothelial Cell Metabolism.Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores.Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats.Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
P2860
Q24338511-B3B8D9E7-3EC6-488D-A0A8-EA3BD617A315Q26782662-F0CDCF51-71F1-4C18-A482-CBFF9173CA36Q26864318-144CB372-30C9-4E9C-8E33-FB6A6D0D2BCCQ28087272-C204C9C4-9FA1-4845-A858-BDFD0075FF01Q30663718-EE5FD782-3694-4FED-AFEB-1C0FDB6E86BCQ30923062-8FB58E62-86CF-4267-87FF-CF94ADB7DF03Q33599633-2E212B42-99E8-4339-9347-52AC29DC98B6Q34556614-E7E959BF-FC9A-41AA-99C1-3284B494AD0EQ35150499-35D76FBD-FEA8-451C-929F-CEE8954E1C6BQ35670550-48371C34-D919-4F4D-968E-28FD08C3A7A7Q36182184-937EDA56-8E2B-4324-A05F-7C8BF5E32471Q37219460-EC6B85F2-B0EE-415C-BF9A-E77DB308D4BEQ37365823-12EFE0A9-47A2-464D-9A55-6E52C041E97DQ37704715-0FE3A958-4B2B-47E4-8CD9-558069C910EFQ38267653-67DF2503-A6FA-41AF-BE10-F579EF07A8B7Q38477549-F7EABC21-C0B3-4ACD-85FE-EE40C97C5D67Q38652256-43E8A46A-6EFA-4111-9888-8B782AF7BE3CQ40267428-0F495D2D-0EDF-4206-A365-18D65EE76D34Q40504192-7BA2E5CE-6166-4E14-9488-C26DC41AF2DBQ40760252-2B729B1A-810F-4EFF-A5FA-CAFAE5AFBCE9Q40987950-C601C23C-E6F0-44A0-B176-040362AE3768Q41120288-C0095D5A-D31A-4051-A953-7549E3292352Q44130923-E7128127-6BCF-42C9-9328-76B29D182E2EQ47860627-369D6460-8D39-4DC0-91EE-247E7D623D77Q48070186-5A3DFB18-325B-46B3-B923-9BF98F9C59AEQ49787990-8DB51B03-C87D-459C-9CB2-CF1FFCB1ABD7Q53583233-021E06F6-0CAE-40D4-9C6C-35D706BBC6ECQ53602954-021256B7-FC91-4FC8-B9F1-E9D2C1DA9F08Q55107043-BD768213-FF3F-4BBA-B3D3-0AE65D1E6D06Q58720737-2998E424-103C-49D2-9D8A-C5CB3480D182
P2860
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Asymmetric and symmetric dimet ...... e: the KAROLA follow-up study.
@en
Asymmetric and symmetric dimet ...... e: the KAROLA follow-up study.
@nl
type
label
Asymmetric and symmetric dimet ...... e: the KAROLA follow-up study.
@en
Asymmetric and symmetric dimet ...... e: the KAROLA follow-up study.
@nl
prefLabel
Asymmetric and symmetric dimet ...... e: the KAROLA follow-up study.
@en
Asymmetric and symmetric dimet ...... e: the KAROLA follow-up study.
@nl
P2093
P2860
P50
P1476
Asymmetric and symmetric dimet ...... e: the KAROLA follow-up study.
@en
P2093
Carla Y Vossen
Edzard Schwedhelm
Lutz P Breitling
Rainer Böger
Renke Maas
P2860
P2888
P304
P356
10.1007/S00392-012-0515-4
P577
2012-10-17T00:00:00Z